Formoterol Fumarate Solution
Product Images NDC 42571-463

This text contains detailed information regarding Formoterol Fumarate Inhalation Solution. The solution is provided in sterile unit-dose vials, individually wrapped for oral inhalation only. Each 2 mL vial contains Formoterol fumarate, USP, along with inactive ingredients such as citric acid monohydrate, trisodium citrate dihydrate, sodium chloride, and water. The carton includes 30 individually wrapped vials. Storage conditions are outlined, including refrigeration prior to dispensing to the patient and subsequent storage options. Instructions are given to healthcare providers and patients on the expiration date, usage, and handling of the product. The manufacturer mentioned is Micro Labs Limited in India, and the manufacturing for the USA is done by Micro Labs USA, Inc. This provides valuable information for both healthcare providers and patients using this medication.*

The text contains information about a medication called Formoterol Fumarate Inhalation Solution, which is supplied in sterile unit-dose vials. Each 2 mL vial consists of active ingredients like Formoterol fumarate and other inactive components. The medication is for oral inhalation only. The product should be stored at specific temperatures both before and after dispensing to the patient. It also provides storage instructions for healthcare providers and patients. The medication is manufactured by Micro Labs Limited in India and distributed by Micro Labs USA, Inc. in Somerset, NJ. Lastly, the text includes a code and revision date for the product.*

This is a comparison of the mean Forced Expiratory Volume in one second (FEV1) measured in liters between two groups. One group was treated with Formoterol fumarate inhalation solution 20 mcg (n=123) and the other group with placebo (n=114).*

This text provides information on the mean Forced Expiratory Volume in one second (FEV1) in Liters for a study comparing Formoterol fumarate inhalation solution 20 mcg with a placebo. The study involved 123 participants for the Formoterol group and 114 participants for the Placebo group.*

This is a description for Formoterol Fumarate Inhalation Solution, containing 20 mcg/2 mL in a sterile unit-dose vial for oral inhalation. The solution consists of Formoterol fumarate as the active ingredient and other inactive components. The storage instructions include refrigeration at 2°C to 8°C and protection from light and heat. The vial should be stored in the foil pouch and used before the expiry date or within 3 months if stored at room temperature (20°C to 25°C). This product is manufactured by Micro Labs USA, Inc., for Micro Labs Limited in India.*

This is an inhalation solution containing Formoterol Fumarate in a 2 mL vial with a concentration of 20 mcg/2 mL. It is manufactured in India and is indicated for oral inhalation use only. The solution is sterile and is recommended to be used before the expiration date of July 2024 (Rev. 07/2024). The National Drug Code (NDC) for this product is 42571-463-75.*